CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib
Condition(s):Metastatic Castration-Resistant Prostate Cancer; Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Other Solid TumorLast Updated:August 15, 2023Completed